Explore our full content library.
IMCD: Portfolio Defensibility & China’s Price Deflation
Jan 13, 2026
Partner Interview
IMCD•NL•Mid CapAzelisBrenntagJan 13, 2026
IMCD, Azelis : Western vs Chinese Principals, Margin Mix and Switching Costs
Jan 7, 2026
Partner Interview
Azelis•BE•Mid CapBrenntagIMCDJan 7, 2026
IMCD: Exclusive Distribution Relationships
Dec 30, 2025
Partner Interview
Azelis•BE•Mid CapIMCDDec 30, 2025
IMCD, Azelis, & Chinese Competition
Dec 4, 2025
Partner Interview
Azelis•BE•Mid CapIMCDDec 4, 2025
Croda: Vaccine Adjuvants Business
Oct 7, 2024
Partner Interview
Croda International•GB•Mid CapBrenntagIMCDAzelisPfizerJohnson & JohnsonBioNTechOct 7, 2024
Croda: Life Sciences Specialty Chemicals
Sep 16, 2024
Partner Interview
Croda International•GB•Mid CapIMCDAzelisBrenntagBasfSep 16, 2024
IMCD: Customer Value-Add
Oct 24, 2023
Partner Interview
IMCD•NL•Mid CapAzelisGivaudan SAOct 24, 2023
IMCD Group: APAC Region, M&A Strategy & Management Changes
Oct 16, 2023
Partner Interview
IMCD•NL•Mid CapAzelisBrenntagOct 16, 2023
IMCD: Principal - Distributor Dynamics
Oct 5, 2023
Partner Interview
IMCD•NL•Mid CapBrenntagAzelisOct 5, 2023
You've reached the end